He posted as a fact that McDougal was canned by United Healthcare. He has absolutely no proof to that effect. I worked 40 years for major corporations like GE and saw many superb employees let go and dead wood, but politically connected employees promoted. Check out Vascular Cures, a non-profit organization: McDougal is on the board with stellar associates.
Dos anyone have a master list of Vbloc centers? Each day I punch in random cities, but never tried Lubbock TX, until today. SWAT Surgical at North Star Surgical center is listed.
Ms McDougal is also on the board of non-profit Vascular Cures. She's in great company as another board member is the EVP of Jazz Pharmaceuticals.
(From Fierce Medal Devices) 7-30-15
One of a handful of obesity devices aiming for the U.S. market has been sidelined. Australian company GI Dynamics has opted, after discussions with the FDA, to terminate its pivotal trial for its EndoBarrier due to safety concerns. The trial had already been placed on hold by the agency in March due to the incidence of hepatic abscess.
(This method really foul and disgusting):
Also this week, another obesity company put its device in front of the agency. Aspire Bariatrics submitted a PMA application for its hand-held device that enables obese patients to drain a portion of consumed food from the stomach directly into the toilet via a small port.
Let me correct you:1) ETRM has never posted jobs on their website but solicited resume submittals, of which they may have received hundreds if not thousands. They have hired a number of people since FDA approval. 2) ETRM's bariatric surgeons are NOT bound by FDA guidelines and can implant as they wish, as long as they can justify their rationale.
My personal experience with an FDA approved medical device: In 1997 I had Lasik surgery, despite being a very poor candidate by FDA guidelines. In 2015, FDA guidelines still frown on me as a Lasik candidate; however, doctors have done tens of thousands of Lasik procedures on poor candidate like me. Happily, my vision results have been and continue to be quite acceptable.
Folks, in the brutal market of programmed trading high frequency trading desks make a fortune devastating hundreds of tiny companies and even some larger ones. A trading bot does not care if your company has a cure for cancer or if your company promotes harmful products. The bot makes no distinction. A little known fact is that high frequency trading desks turn a daily profit 90% of the time.
We have a device approved for sale in countries having a population of about one billion, two CE marks and an additional one pending, and the FDA seal of approval. I really believe that ETRM is working 24/7 on closing a partnership or buyout deal.
Both times the negative articles by the same person came out DURING market hours and when the stock price was attempting a minor rally. Both times the price plunged suspiciously.
Lobsterpot 1989: Friedman and Shikora are the most valuable assets for Enteromedics. The board member bought ETRM shares last year and has a ton of contacts through her years at investment bank heavyweight Morgan Stanley. Shikora has high visibility and can still make money on his stock options if ETRM gets sold for $2 or more. He would probably stay on with at least a lucrative consulting contract with an acquiring company.
Yes. Encysive (ENCY) went as high as $7.10 and was rumored to have had a $10 buyout offer (of course, never made public by self-serving management). After an FDA rejection of their drug THELIN, shorts drove it as low as 59 cents. The company did hire an investment bank to shop the company. Over 100 pitch books were sent out and at least 12 suitors signed confidentiality agreements, with six making actual bids. Pfizer won with a $2.35 share buyout and 100% assumption of $140 million in debt. ENCY was so low on funds PFE had to advance them an immediate $6 million to keep the door open. This was in 2007.
Multiple deaths happened a the California lap band clinics. The FDA instigated the clinic investigations. It's not inconceivable that the lap band horror stories might have been a deciding factor in the approval of Vbloc.
April 24, 2015(Los Angeles Times)
Federal agents have seized $109 million in cash and securities during an ongoing investigation of the businesses and individuals behind the 1-800-GET-THIN ad campaign for weight-loss surgery.
Authorities seized $92 million from 12 Deutsche Bank accounts June 4 and $17 million from two Bank of America accounts June 24, according to a motion filed by Assistant U.S. Atty. Steven Welk, who oversees the asset forfeiture division of the U.S. attorney's office in Los Angeles.
Next PR could also be announcing that Vbloc has received the additional CE mark for hypertension. First was CE mark for obesity, then a CE mark for diabetes.
"EnteroMedics® has significant clinical experience with VBLOC® vagal blocking therapy; more than 600 patients have been implanted with the Maestro® System to date."
(7/2/15 - see website under United States, Clinical experience)